Chelation therapy (Pronounced key-lay-shun) is a medical procedure used in conventional medicine that involves the administration of chelating agents to remove heavy metals from the body. It involves intravenous injections of a chelating agent, EDTA (ethylene diamine tetra-acetic acid), a synthetic amino acid. EDTA binds to heavy metals and minerals in the blood so that they can be excreted in the urine.
However because EDTA can reduce the amount of calcium in the bloodstream, and because calcium is found within the plaque that can line diseased blood vessels, chelation therapy can be used to treat atherosclerosis (hardening of the arteries) by reopening arteries clogged with plaque.
Heavy metal catalysts induce chemical reactions and cause damage to the cell membranes by producing free radicals. Free radical damage is an important cause of Aging, Atherosclerosis and Cancer. By aiding the removal of heavy metals, EDTA helps reduce production of free radicals, hence preventing major diseases.
Atherosclerotic plaque, after many years has the tendency to become calcified. Calcium tends to deposit close to the atheroma and also on the atheroma plaques and surface. EDTA can reduce the amount of calcium in the bloodstream thereby reopening arteries affected by such plaque as well as reducing further incidence of formation and worsening.
The normal aging process causes calcium deposition in the arterial wall making the artery harder and less pliable. EDTA reverses this process and improves Blood pressure and blood supply to the extremities.
EDTA improves calcium metabolism by stimulating secretion of Parathyroid hormone. EDTA can thus improve bone density over time.
Anyone with circulatory problems can undergo Chelation therapy. Patients who have had a history of stroke or heart disease will benefit from the treatment. Patients with family history of circulatory diseases can also be considered for treatment.
Heavy metal toxicity
Peripheral Artery Disease
High blood pressure
Parkinson’s disease and Alzheimer’s disease
Aging or Memory loss
Chelation can, and is used as a prophylactic and preventive measure against Atherosclerosis in non-symptomatic people, especially high risk individuals. This can prevent many complications in the future.
EDTA chelation therapy is relatively non-toxic and risk-free, especially when compared with other treatments. The risk of significant side effects, when properly administered, is less than 1 in 10,000 patients treated. More than 400,000 patients have received over four million treatments during the past 30 years. It is estimated by the American College for Advancement in Medicine, a professional association that supports the use of chelation therapy, that more than 800,000 visits for chelation therapy were made in the United States in 1997 alone.
A burning sensation at the site of the injection is the most common side effect following treatment. Some temporarily experience mild nausea, dizziness, or headache as an immediate aftermath of treatment, but in the vast majority of cases, these minor symptoms are easily relieved.
Chelation therapy usually consists of anywhere from 20 to 40 separate infusions, depending on each patient’s individual health status. Patients with symptoms of Arterial blockage will require a minimum of 30 sittings for optimum benefit. As a prophylactic measure, Healthy patients would require around 20 sittings.
Each Chelation treatment takes three hours or longer and patients receive treatment weekly or twice weekly as per their convenience and schedule.
Chelation is an out-patient procedure and the patient does not need admission for treatment.